These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 15047820)

  • 1. Induction of autoantibodies to CCR5 in macaques and subsequent effects upon challenge with an R5-tropic simian/human immunodeficiency virus.
    Chackerian B; Briglio L; Albert PS; Lowy DR; Schiller JT
    J Virol; 2004 Apr; 78(8):4037-47. PubMed ID: 15047820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of immunization with CCR5-based cycloimmunogen on simian/HIVSF162P3 challenge.
    Misumi S; Nakayama D; Kusaba M; Iiboshi T; Mukai R; Tachibana K; Nakasone T; Umeda M; Shibata H; Endo M; Takamune N; Shoji S
    J Immunol; 2006 Jan; 176(1):463-71. PubMed ID: 16365439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced infectivity of an R5-tropic simian/human immunodeficiency virus carrying human immunodeficiency virus type 1 subtype C envelope after serial passages in pig-tailed macaques (Macaca nemestrina).
    Chen Z; Huang Y; Zhao X; Skulsky E; Lin D; Ip J; Gettie A; Ho DD
    J Virol; 2000 Jul; 74(14):6501-10. PubMed ID: 10864663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques.
    Hovanessian AG; Soundaramourty C; Benferhat R; Le Grand R; Dereuddre-Bosquet N; Krust B; Estaquier J
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral evolution in macaques coinfected with CCR5- and CXCR4-tropic SHIVs in the presence or absence of vaccine-elicited anti-CCR5 SHIV neutralizing antibodies.
    Burke B; Derby NR; Kraft Z; Saunders CJ; Dai C; Llewellyn N; Zharkikh I; Vojtech L; Zhu T; Srivastava IK; Barnett SW; Stamatatos L
    Virology; 2006 Nov; 355(2):138-51. PubMed ID: 16920175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A vaccine against CCR5 protects a subset of macaques upon intravaginal challenge with simian immunodeficiency virus SIVmac251.
    Van Rompay KK; Hunter Z; Jayashankar K; Peabody J; Montefiori D; LaBranche CC; Keele BF; Jensen K; Abel K; Chackerian B
    J Virol; 2014 Feb; 88(4):2011-24. PubMed ID: 24307581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaques.
    Ho SH; Shek L; Gettie A; Blanchard J; Cheng-Mayer C
    J Virol; 2005 Oct; 79(19):12296-303. PubMed ID: 16160156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of CD8+ cells able to suppress CCR5-tropic simian immunodeficiency virus SIVmac239 replication by controlled infection of CXCR4-tropic simian-human immunodeficiency virus in vaccinated rhesus macaques.
    Tsukamoto T; Yuasa M; Yamamoto H; Kawada M; Takeda A; Igarashi H; Matano T
    J Virol; 2007 Nov; 81(21):11640-9. PubMed ID: 17728225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic infection of Macaca nemestrina with a CCR5-tropic subtype-C simian-human immunodeficiency virus.
    Ho O; Larsen K; Polacino P; Li Y; Anderson D; Song R; Ruprecht RM; Hu SL
    Retrovirology; 2009 Jul; 6():65. PubMed ID: 19602283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.
    Someya K; Cecilia D; Ami Y; Nakasone T; Matsuo K; Burda S; Yamamoto H; Yoshino N; Kaizu M; Ando S; Okuda K; Zolla-Pazner S; Yamazaki S; Yamamoto N; Honda M
    J Virol; 2005 Feb; 79(3):1452-62. PubMed ID: 15650171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate differences between simian-human immunodeficiency virus (SHIV)(KU-2)-infected rhesus and pig-tailed macaques in development of neurological disease.
    Buch SJ; Villinger F; Pinson D; Hou Y; Adany I; Li Z; Dalal R; Raghavan R; Kumar A; Narayan O
    Virology; 2002 Mar; 295(1):54-62. PubMed ID: 12033765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Strategy To Adapt Simian-Human Immunodeficiency Virus E1 Carrying
    Scinto HB; Gupta S; Thorat S; Mukhtar MM; Griffiths A; Delgado J; Plake E; Vyas HK; Strickland A; Byrareddy SN; Montefiori DC; LaBranche C; Pal R; Treece J; Orndorff S; Ferrari MG; Weiss D; Chenine AL; McLinden R; Michael N; Kim JH; Robb ML; Rerks-Ngarm S; Pitisuttithum P; Nitayaphan S; Ruprecht RM
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of immune responses and break of tolerance by DNA against the HIV-1 coreceptor CCR5 but no protection from SIVsm challenge.
    Zuber B; Hinkula J; Vödrös D; Lundholm P; Nilsson C; Mörner A; Levi M; Benthin R; Wahren B
    Virology; 2000 Dec; 278(2):400-11. PubMed ID: 11118363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of inhibitory antibodies to the CCR5 chemokine receptor and their complementary role in preventing SIV infection in macaques.
    Lehner T; Wang Y; Doyle C; Tao L; Bergmeier LA; Mitchell E; Bogers WM; Heeney J; Kelly CG
    Eur J Immunol; 1999 Aug; 29(8):2427-35. PubMed ID: 10458756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infectious simian/human immunodeficiency virus with human immunodeficiency virus type 1 subtype C from an African isolate: rhesus macaque model.
    Ndung'u T; Lu Y; Renjifo B; Touzjian N; Kushner N; Pena-Cruz V; Novitsky VA; Lee TH; Essex M
    J Virol; 2001 Dec; 75(23):11417-25. PubMed ID: 11689623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV).
    Luciw PA; Pratt-Lowe E; Shaw KE; Levy JA; Cheng-Mayer C
    Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7490-4. PubMed ID: 7638218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of the extracellular domains of C-C chemokine receptor 5 and the in vitro effects on simian immunodeficiency virus or HIV infectivity.
    Lehner T; Doyle C; Wang Y; Babaahmady K; Whittall T; Tao L; Bergmeier L; Kelly C
    J Immunol; 2001 Jun; 166(12):7446-55. PubMed ID: 11390497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenic simian/human immunodeficiency virus SHIV(KU) inoculated into immunized macaques caused infection, but virus burdens progressively declined with time.
    Silverstein PS; Mackay GA; Mukherjee S; Li Z; Piatak M; Lifson JD; Narayan O; Kumar A
    J Virol; 2000 Nov; 74(22):10489-97. PubMed ID: 11044093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a simian human immunodeficiency virus encoding the envelope gene from the CCR5-tropic HIV-1 Ba-L.
    Pal R; Taylor B; Foulke JS; Woodward R; Merges M; Praschunus R; Gibson A; Reitz M
    J Acquir Immune Defic Syndr; 2003 Jul; 33(3):300-7. PubMed ID: 12843740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV(SF162P3).
    Harouse JM; Gettie A; Eshetu T; Tan RC; Bohm R; Blanchard J; Baskin G; Cheng-Mayer C
    J Virol; 2001 Feb; 75(4):1990-5. PubMed ID: 11160699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.